Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

In-Process Control: SOP for Real-Time Monitoring of Vial Fill Levels – V 2.0

Posted on By

In-Process Control: SOP for Real-Time Monitoring of Vial Fill Levels – V 2.0

Standard Operating Procedure for Real-Time Monitoring of Vial Fill Levels


Department In-Process Control
SOP No. SOP/IPC/172/2025
Supersedes SOP/IPC/172/2022
Page No. Page 1 of 15
Issue Date 24/06/2025
Effective Date 25/06/2025
Review Date 24/06/2026

1. Purpose

This SOP describes the process and responsibilities for real-time monitoring of vial fill levels during sterile injectable manufacturing to ensure consistent fill volumes, reduce product rejects, and comply with GMP and regulatory requirements.

2. Scope

This procedure applies to all

vial filling operations for sterile injectable products across all filling lines equipped with online vision systems, electronic sensors, or gravimetric monitoring systems used at [Insert Company Name]’s sterile manufacturing facility.

3. Responsibilities

  • Machine Operator: To continuously observe the vial fill levels via HMI and visual inspection. Promptly report discrepancies to the Production Supervisor.
  • In-Process Quality Assurance (IPQA) Officer: To verify fill level compliance, review alerts and rejection trends, and record real-time checks.
  • Production Supervisor: To assess machine performance, authorize interventions, and coordinate with engineering when variances occur.
  • Engineering/Maintenance: To calibrate, maintain, and troubleshoot vial fill level detection systems and associated hardware.
  • QA Manager: To review the monitoring records and ensure procedural compliance during audits.

4. Accountability

The Production Head is accountable for the effective implementation of this SOP and ensuring appropriate corrective actions in case of anomalies in vial fill levels.

See also  Sterile Injectable Manufacturing: SOP for Use of CIP (Clean-In-Place) Systems in Injectable Manufacturing - V 2.0

5. Procedure

5.1 System Setup and Verification

  1. Ensure the vial filling line is prepared, and all cleaning and line clearance activities are completed and documented.
  2. Verify that the vial fill level monitoring system is active, clean, calibrated, and functional. This includes:
    • Camera lenses or sensors (capacitive, gravimetric, or infrared)
    • Associated software and rejection mechanisms
    • Alarms and interface displays
  3. Initiate a dry run with empty or filled test vials to confirm alignment and sensitivity of the monitoring system.

5.2 Monitoring During Filling

  1. Begin batch filling after receiving QA clearance.
  2. The real-time vial fill level detection system shall evaluate each vial after it passes the filling station and before sealing.
  3. Set acceptable fill limits as per the validated batch manufacturing record (e.g., 5.0 ± 0.1 mL).
  4. The system shall automatically:
    • Accept correctly filled vials
    • Reject underfilled or overfilled vials
    • Log data for each rejection
  5. Rejected vials must be collected in the designated rejection bin and recorded in the Fill Volume Rejection Log (Annexure-1).

5.3 Manual Checks

  1. Every 30 minutes, IPQA must collect 5 vials for manual verification using a calibrated analytical balance or visual comparator.
  2. Record each observation in the Manual Fill Check Log (Annexure-2).
  3. If deviation is observed beyond acceptance criteria, stop the line and inform QA and maintenance for investigation.
See also  Sterile Injectable Manufacturing: SOP for Sealing and Labeling of Injectable Vials - V 2.0

5.4 Rejection Limits and Alerts

  1. System shall trigger an alert if:
    • More than 3 consecutive fill rejections occur
    • Total rejections exceed 2% of batch size
    • Sensor or system malfunction is detected
  2. Immediately pause the machine on alert and initiate deviation documentation (Annexure-3).
  3. Engineering and QA shall jointly assess root cause and implement CAPA if needed.

5.5 Data Logging and Batch Summary

  1. The system shall generate continuous logs of:
    • Each vial’s fill level
    • Time of rejection
    • Batch number and operator ID
  2. Post batch completion, export and attach the electronic summary report to the BMR.
  3. Ensure backups are maintained for a minimum of 5 years.

5.6 Equipment Calibration and Maintenance

  1. Monthly calibration of sensors and cameras must be performed and documented (refer SOP/ENG/045).
  2. Corrective adjustments and preventive maintenance schedules shall be defined based on equipment manuals.
  3. Calibration certificates and maintenance logs must be available during audits.

5.7 Deviation Handling

  1. All fill volume deviations, equipment malfunctions, or procedural lapses must be captured in deviation form (Annexure-3).
  2. QA must investigate the incident, determine impact on batch quality, and recommend batch disposition.
  3. CAPA shall be closed within 30 days and reviewed during internal quality audits.
See also  Quality Assurance: SOP for Establishing Critical Quality Attributes for Sterile Products - V 2.0

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPQA: In-Process Quality Assurance
  • BMR: Batch Manufacturing Record
  • CAPA: Corrective and Preventive Action

7. Documents

  1. Fill Volume Rejection Log – Annexure-1
  2. Manual Fill Check Log – Annexure-2
  3. Deviation Form – Annexure-3

8. References

  • 21 CFR Part 211 – CGMP for Finished Pharmaceuticals
  • EU GMP Annex 1: Manufacture of Sterile Medicinal Products
  • ICH Q9: Quality Risk Management

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Production Executive QA Executive Head QA
Department Production Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Fill Volume Rejection Log

Date Batch No. Vial No. Fill Volume (mL) Rejection Type Operator
24/06/2025 VIAL0625-03 105 4.8 Underfill Rajesh Kumar

Annexure-2: Manual Fill Check Log

Date Batch No. Vial No. Observed Volume Result Checked By
24/06/2025 VIAL0625-03 3 5.05 mL Acceptable Sunita Reddy

Annexure-3: Deviation Form

Deviation No. DEV/IPC/067
Date 24/06/2025
Observed By Rajesh Kumar
Description Increased underfill rate detected after 11:45 AM
Immediate Action Machine stopped, maintenance informed
Root Cause Pressure fluctuation in fill nozzle
CAPA Replaced pneumatic valve, calibrated sensor

Revision History:

Revision Date Revision No. Details Reason Approved By
15/04/2022 1.0 Initial Release New SOP QA Head
24/06/2025 2.0 Updated with electronic monitoring and annexures Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Gel Manufacturing: SOP for Development of Oil-Based Gels – V 2.0
Next Post: Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version